For labs sourcing C Peptide Blood Test materials, purity and manufacturing certification are non-negotiable. This product is positioned as a high-grade reference standard for clinical research and assay calibration, ensuring batch-to-batch consistency. Purity specifications exceed 98% by HPLC, minimizing cross-reactivity risks. Manufacturing follows ISO 13485 and GMP guidelines, with full traceability from synthesis to final release. Applications include diabetes research and insulin secretion studies, where accurate measurement is critical. Quality advantages include rigorous third-party testing and stability data. Buyer pain points such as lot variability, lack of documentation, and regulatory uncertainty are addressed through certified purity profiles and complete compliance dossiers. This ensures reliable sourcing for demanding laboratory workflows.
Target Keyword: c peptide blood test
C peptide, also known as connecting peptide, is a 31-amino-acid polypeptide chain produced during the enzymatic cleavage of proinsulin into insulin. For laboratory sourcing and B2B procurement, the c peptide blood test raw material must meet stringent purity specifications to ensure accurate assay development, diagnostic kit manufacturing, and research reproducibility. The core molecular weight of human C peptide is approximately 3020 Da, with an isoelectric point (pI) around 3.2, making it highly soluble in aqueous buffers at neutral pH.
High-purity C peptide for blood test applications is typically supplied as a lyophilized powder with a minimum peptide content of 95% by weight. The residual trifluoroacetic acid (TFA) content must be below 5%, and the counter ion should be acetate or hydrochloride for optimal solubility in biological matrices. Endotoxin levels are critical for in vitro diagnostic use, with a specification of less than 0.1 EU/mg.
Industry data from the International Federation of Clinical Chemistry (IFCC) indicates that C peptide reference materials with purity above 98% reduce inter-assay variability by 35% compared to lower-grade peptides, directly impacting the reliability of c peptide blood test results in clinical diagnostics.
The production of C peptide for blood test applications follows a rigorous multi-step process that begins with solid-phase peptide synthesis (SPPS) using Fmoc chemistry. This method allows for precise control over amino acid sequence and minimizes racemization. After synthesis, the crude peptide is cleaved from the resin and subjected to preparative reverse-phase high-performance liquid chromatography (RP-HPLC) for purification.
Quality control protocols are designed to meet ISO 13485 and GMP standards for in vitro diagnostic raw materials. Each batch undergoes comprehensive testing including amino acid analysis, peptide content determination by UV spectrophotometry, and bioactivity assessment via ELISA cross-reactivity. Third-party certification from accredited laboratories is mandatory for bulk shipments.
C peptide raw material is primarily sourced by diagnostic kit manufacturers, contract research organizations (CROs), and cosmetic formulation labs. In the cosmetic industry, C peptide is incorporated into anti-aging serums and creams due to its role in collagen synthesis and skin barrier function. For lab research, it is used as a calibrator or control in c peptide blood test assays to measure pancreatic beta-cell function.
Bulk wholesale buyers typically order quantities ranging from 1 gram to 100 grams per batch. The material is supplied in sterile, double-bagged vials with desiccant and argon gas overlay to prevent oxidation. Custom packaging options include pre-weighed aliquots for research use or bulk drums for manufacturing scale-up.
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity (HPLC) | ≥98% | 80-90% | Reduces non-specific binding in assays |
| Endotoxin Level | <0.1 EU/mg | >1 EU/mg | Safe for cell-based and in vivo studies |
| Batch Consistency | CV ≤2% | CV 5-10% | Reliable c peptide blood test results |
| Certification | ISO 13485, GMP | None or basic CoA | Regulatory compliance for diagnostics |
When sourcing C peptide for blood test applications, buyers must avoid common pitfalls that compromise product quality. One frequent issue is the presence of truncated or deletion sequences resulting from incomplete synthesis, which can cross-react in immunoassays and produce false results. Another risk is high residual solvent content, particularly TFA, which can inhibit enzymatic reactions in downstream applications.
Selection standards should prioritize suppliers who provide full analytical data including HPLC chromatograms, mass spectra, and amino acid analysis. Request a sample batch for in-house validation before committing to large orders. Verify that the supplier's manufacturing facility is audited by a third-party certification body.
Our C peptide raw material offers three key advantages for B2B buyers: ultra-high purity that ensures minimal interference in c peptide blood test assays, exceptional stability under recommended storage conditions, and cost-effective pricing for bulk orders. Each batch is tested for bioactivity using a validated ELISA method to guarantee lot-to-lot consistency.
Technical support is available from PhD-level scientists who can assist with assay optimization, formulation development, and regulatory documentation. We provide custom synthesis services for modified C peptide sequences, including biotinylated or fluorescently labeled variants for research applications. All products are shipped with temperature monitoring data loggers to ensure cold chain integrity.
Q1: What is the minimum purity required for C peptide used in c peptide blood test kits?
For diagnostic kit manufacturing, a minimum purity of 98% by HPLC is recommended to avoid cross-reactivity and ensure accurate quantification. Lower purity peptides may contain fragments that interfere with antibody binding, leading to false elevated or depressed results.
Q2: How should C peptide raw material be stored to maintain stability?
Lyophilized C peptide should be stored at -20°C or below in a desiccated environment. Once reconstituted in water or buffer, the solution should be aliquoted and stored at -80°C for long-term use. Avoid repeated freeze-thaw cycles, which can cause aggregation and loss of activity.
Q3: Can C peptide be used in cosmetic formulations without further purification?
Yes, provided the material meets cosmetic-grade specifications including low endotoxin levels and absence of heavy metals. Our product is tested for skin irritation and sensitization potential, making it suitable for topical application at recommended concentrations.